Casandra
Casandra Test Code AR51544Version 1 (DRAFT)
Performing Lab
Autoimmune Movement Disorder Panel, CSF (Change effective as of 4/21/25: Refer to 3018966 in the April Hotline)
Also known as: AIMDC
Clinical Use
Order TestUse
This panel is used to evaluate subacute‑onset movement disorders by detecting a range of neuronal autoantibodies in cerebrospinal fluid that are associated with autoimmune movement disorders. Identification of these antibodies can support diagnosis, guide clinical management, and inform evaluation for underlying causes including paraneoplastic syndromes.
Special Instructions
Change effective as of April 21, 2025: this test is being replaced; refer to test 3018966 (Autoimmune Movement Disorder Panel, CSF) in the April Hotline or test directory for the current orderable version.
Limitations
Not stated explicitly in the provided content.
Test Details
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
16 targets
AMPA Receptor AbAmphiphysin AntibodyCASPR2 AbCV2 AbDPPX AbGABA‑AR AbGABA‑BR AbGlutamic Acid Decarboxylase Antibody+8 more
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Not provided.